MxA/Mx1 Antibody [Alexa Fluor® 750]

• Applications: WB, IHC, ICC/IF
• Clonality: Polyclonal
• Host: Goat
• Conjugate: Alexa Fluor 750

MxA/Mx1 Antibody [Alexa Fluor® 750] Summary

• Immunogen: E. coli-derived recombinant human MxA/Mx1
  His412-Leu630
  Accession # P20591
• Specificity: Detects human MxA/Mx1 in direct ELISAs and Western blots.
• Source: N/A
• Isotype: IgG
• Clonality: Polyclonal
• Host: Goat
• Purity Statement: Antigen Affinity-purified

Packaging, Storage & Formulations

• Storage: Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied
• Buffer: Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Background

MxA (orthoMyxovirus-resistant protein A; also IFN-induced protein p78/IFI-78K and Mx1) is a 75-78 kDa member of the Dynamin family, GTPase-binding superfamily of proteins.  It is induced by type I and III interferons, and is known to reside in the cytoplasm and associate with the membranes of the ER.  Typically, IFN-alpha is produced when influenza virus RNA (plus other viral dsDNA and RNA) is detected by internal Pattern recognition receptors (PRRs).  IFN-alpha induces the synthesis of 300+ genes, one of which is MxA (Mx1 in mouse).  In primates, MxA is cytoplasmic, and interacts with the influenza virus replication cycle at a point proximal to the transcription of genomic RNA into mRNA. By contrast, Mx1 in mouse acts in the nucleus to block primary viral gene transcription.  Functionally, MxA is a GTPase, but it is only the binding of GTP to MxA that is associated with antiviral activity.  Nucleotide binding to MxA is also associated with nonviral activity, being associated with the potentiation of TRPC Ca²⁺ channel activity.  Human MxA is 662 amino acids (aa) in length.  It contains one GTPase domain (aa 69-340) and a GED (GTPase Effector Domain) over aa 574-662.  There are two ultilized phosphorylation sites at Tyr129 and Tyr451.  MxA forms homo-dimers, -tetramers and -oligomers, with multimerization suggested to be important for activity.  Although IFNs are typically considered to induce Mx gene expression, HSV-1 itself also activates gene transcription.  In this case, however, a truncated 54-57 kDa transcript is generated that contains an 84 aa substitution for aa 425-662. Over aa 412-630, human MxA shares 49% aa sequence identity with mouse Mx1.   

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.